Title: Berangere Vasseur-Demarcy: Innovator in Chemotherapy Treatment
Introduction
Berangere Vasseur-Demarcy is a notable inventor based in France. She has made significant contributions to the field of medicine, particularly in the area of chemotherapy treatment. Her work focuses on developing innovative solutions to mitigate the adverse side effects of chemotherapy.
Latest Patents
Berangere Vasseur-Demarcy holds a patent related to "Clonidine AND/OR Clonidine Derivatives For Use In The Prevention AND/OR Treatment Of Adverse Side Effects Of Chemotherapy." This invention pertains to a clonidine and/or clonidine derivative formulated for transmucosal administration. It is designed for use in the prevention and/or treatment of asthenia and/or fatigue due to alkylating agent chemotherapy. The specific compounds involved in this patent are selected based on a detailed chemical formula, which includes various substituents and functional groups.
Career Highlights
Berangere is currently associated with Monopar Therapeutics, Inc., where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for patients undergoing chemotherapy.
Collaborations
She collaborates with Pierre Attali, contributing to the innovative research environment at Monopar Therapeutics, Inc.
Conclusion
Berangere Vasseur-Demarcy is a dedicated inventor whose work aims to improve the quality of life for chemotherapy patients. Her innovative approach to addressing treatment side effects showcases her commitment to medical advancements.